Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Condition:   Breast Cancer Intervention:   Drug: apatinib+oral etoposide Sponsor:   Chinese Academy of Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials